GOG-254 - A Phase II Evaluation of SU11248 (Sunitinib Malate) (IND 74019, NSC 736511) in the Treatment of Persistent or Recurrent Clear Cell Ovarian Carcinoma

Clinical Trial Categories

  • Ovarian Cancer
Contact
Hanjani Institute for Gynecologic Oncology at 215-885-0220

Location

  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740